Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study.

Autor:	San-Miguel, J. F.1 sanmigiz@usal.es, Richardson, P. G.2, Sonneveld, P.3, Schuster, M. W.4, Irwin, D.5, Stadtmauer, E. A.6, Facon, T.7, Harousseau, J.-L.8, Ben-Yehuda, D.9, Lonial, S.10, Goldschmidt, H.11, Reece, D.12, Bladé, J.13, Boccadoro, M.14, Cavenagh, J. D.15, Neuwirth, R.16, Boral, A. L.16, Esseltine, D.-L.16, Anderson, K. C.2
Zdroj:	Leukemia (08876924). Apr2008, Vol. 22 Issue 4, p842-849. 8p. 4 Charts, 2 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu